Search

everythinglearnresearchcommunity

for

Search:↓

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

The study identified key immune cell differences between mild and severe alopecia areata.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.